Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Morphic Holding Inc (MORF)
Morphic Holding Inc (MORF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,977,962
  • Shares Outstanding, K 50,037
  • Annual Sales, $ 520 K
  • Annual Income, $ -152,100 K
  • 60-Month Beta 1.43
  • Price/Sales 3,548.69
  • Price/Cash Flow N/A
  • Price/Book 2.68
Trade MORF with:

Options Overview Details

View History
  • Implied Volatility 89.17% ( +21.09%)
  • Historical Volatility 58.89%
  • IV Percentile 80%
  • IV Rank 28.42%
  • IV High 189.72% on 04/18/23
  • IV Low 49.26% on 06/15/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 738
  • Open Int (30-Day) 1,023

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.96
  • Number of Estimates 4
  • High Estimate -0.82
  • Low Estimate -1.17
  • Prior Year -0.90
  • Growth Rate Est. (year over year) -6.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.34 +22.23%
on 02/02/24
41.47 -4.68%
on 02/12/24
+4.85 (+13.99%)
since 02/01/24
3-Month
24.22 +63.21%
on 12/04/23
41.47 -4.68%
on 02/12/24
+15.12 (+61.94%)
since 12/01/23
52-Week
19.34 +104.34%
on 11/01/23
63.08 -37.34%
on 06/12/23
-4.15 (-9.50%)
since 03/01/23

Most Recent Stories

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Morphic Holding, Inc. ("Morphic" or the "Company") (NASDAQ: MORF). Such...

MORF : 39.53 (+6.98%)
MORF INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

/PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Morphic...

MORF : 39.53 (+6.98%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Morphic Holding, Inc. (MORF)

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Morphic Holding, Inc. ("Morphic" or the "Company") (NASDAQ: MORF). Such...

MORF : 39.53 (+6.98%)
MillerKnoll, Peloton rise; Progress Software, NextEra Energy fall, Wednesday, 9/27/2023

Stocks that traded heavily or had substantial price changes on Wednesday: MillerKnoll, Peloton rise; Progress Software, NextEra Energy fall

AIR : 66.62 (-0.24%)
PTON : 4.60 (+1.77%)
PRGS : 53.35 (-0.02%)
NEE : 55.21 (+0.04%)
AN : 151.98 (+1.46%)
MORF : 39.53 (+6.98%)
Stocks Recover Early Losses on Soft Landing Optimism for the U.S. Economy

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.40%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up...

$SPX : 5,137.08 (+0.80%)
SPY : 512.85 (+0.94%)
$DOWI : 39,087.38 (+0.23%)
DIA : 391.31 (+0.35%)
$IUXX : 18,302.91 (+1.44%)
QQQ : 445.61 (+1.51%)
SEE : 34.76 (-0.32%)
DOW : 55.77 (-0.20%)
NVDA : 822.79 (+4.00%)
AMZN : 178.22 (+0.83%)
STLD : 133.71 (-0.08%)
CLF : 21.08 (+1.35%)
Stocks Mixed as Global Bond Yields Climb

The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq ($IUXX ) (QQQ ) is up +0.26%. Stocks are mixed, with the S&P 500 earlier...

$SPX : 5,137.08 (+0.80%)
SPY : 512.85 (+0.94%)
$DOWI : 39,087.38 (+0.23%)
DIA : 391.31 (+0.35%)
$IUXX : 18,302.91 (+1.44%)
QQQ : 445.61 (+1.51%)
UAL : 44.84 (-1.43%)
AAL : 15.66 (-0.13%)
DAL : 42.16 (-0.26%)
ALK : 37.00 (-1.04%)
LUV : 33.96 (-0.90%)
CCL : 16.00 (+0.88%)
Markets Today: Stocks Lower on Concern about Hawkish Global Central Banks

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.32%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.33%. Stock index futures this morning are mildly lower, following losses...

ESH24 : 5,146.00s (+0.83%)
NQH24 : 18,338.25s (+1.41%)
FL : 34.60 (+0.49%)
URBN : 42.22 (+1.61%)
NKE : 101.88 (-1.62%)
DXCM : 121.74 (+5.80%)
HPQ : 29.41 (+3.81%)
MORF : 39.53 (+6.98%)
WBD : 8.67 (-1.37%)
PARA : 10.95 (-0.82%)
DIS : 111.95 (+0.33%)
NFLX : 619.34 (+2.72%)
3 Biotech Buyout Targets to Watch

The trio all have late-stage therapies with blockbuster potential.

ETNB : 12.62 (+10.03%)
KRTX : 316.24 (+0.72%)
MORF : 39.53 (+6.98%)
The Zacks Analyst Blog Highlights Biogen, Incyte, Morphic Therapeutic and bluebird bio

Biogen, Incyte, Morphic Therapeutic and bluebird bio are included in this Analyst Blog.

BIIB : 220.95 (+1.82%)
INCY : 59.05 (+1.18%)
BLUE : 1.5650 (+12.59%)
MORF : 39.53 (+6.98%)
Biotech Stock Roundup: BIIB's Q1 Results, ARWR Up on Data, INCY & BLUE Offer Updates

Earnings and pipeline updates from Biogen (BIIB) and Arrowhead (ARWR) are they key highlights of the biotech sector.

BIIB : 220.95 (+1.82%)
INCY : 59.05 (+1.18%)
ARWR : 36.08 (+12.40%)
BLUE : 1.5650 (+12.59%)
MORF : 39.53 (+6.98%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Morphic Holding Inc. is a biopharmaceutical company. It focuses on the discovery and development of oral small-molecule integrin therapeutics for autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Morphic Holding Inc. is based in Waltham, Massachusetts.

See More

Key Turning Points

3rd Resistance Point 43.38
2nd Resistance Point 41.55
1st Resistance Point 40.54
Last Price 39.53
1st Support Level 37.69
2nd Support Level 35.86
3rd Support Level 34.85

See More

52-Week High 63.08
Fibonacci 61.8% 46.37
Fibonacci 50% 41.21
Last Price 39.53
Fibonacci 38.2% 36.05
52-Week Low 19.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar